homovanillic acid has been researched along with paroxetine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dwork, A; Huang, YY; Parsons, B; Roxas, A; Stanley, M | 1 |
| Culp, S; DeSouza, EB; Lehmann, J; Zaczek, R | 1 |
| Alling, C; Dalgaard, L; Lundmark, J; Manniche, PM; Wålinder, J | 1 |
| Goodnick, PJ; Henry, J; Kumar, A | 1 |
| Gerber, J; Jimerson, D; Salzman, C; Vasile, R; Watsky, E | 1 |
| Feldtrauer, JJ; Germer, M; Graf, T; Howald, H; Waldmeier, PC | 1 |
| Kamei, K; Kitera, K; Mikuni, M; Muneoka, K; Ogawa, T; Takahashi, K; Takigawa, M | 1 |
| Aguirre, N; Hervías, I; Lasheras, B | 1 |
| Buckland, P; Deslandes, PN; Pache, DM; Sewell, RD | 1 |
| Nakamura, J; Okamoto, K; Shinkai, K; Ueda, N; Yoshimura, R | 1 |
| Goto, M; Kaji, K; Kakihara, S; Nakamura, J; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R | 1 |
| Castro, WL; Delgado, PL; El Khoury, A; Mathé, AA; Misiaszek, J; Moreno, FA; Palmer, C; Parkinson, D; Wright, R | 1 |
| Amianto, F; Brambilla, F; Dalle Grave, R; Fassino, S | 1 |
| Farooq, AD; Naqvi, S; Rahman, R; Zeb, F | 1 |
5 trial(s) available for homovanillic acid and paroxetine
| Article | Year |
|---|---|
Response to SSRI antidepressants correlates with reduction in plasma HVA: pilot study.
Topics: Adult; Aged; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Homovanillic Acid; Humans; Hydrocortisone; Male; Middle Aged; Paroxetine; Personality Inventory; Pilot Projects; Prolactin; Treatment Outcome | 1993 |
Serotonin uptake inhibition by the monoamine oxidase inhibitor brofaromine.
Topics: Adult; Depressive Disorder; Homovanillic Acid; Humans; Male; Monoamine Oxidase Inhibitors; Paroxetine; Piperidines; Placebos; Selective Serotonin Reuptake Inhibitors | 1993 |
Risperidone in the treatment of psychotic depression.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antipsychotic Agents; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Time Factors | 2006 |
CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls.
Topics: Adult; Analysis of Variance; Case-Control Studies; Chromatography, High Pressure Liquid; Circadian Rhythm; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Electrochemistry; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Indoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurochemistry; Neuropeptide Y; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Tryptophan; Young Adult | 2010 |
Lack of efficacy of psychological and pharmacological treatments of disorders of eating behavior: neurobiological background.
Topics: Administration, Oral; Adult; Analysis of Variance; Anorexia Nervosa; Antipsychotic Agents; Benzodiazepines; Bulimia Nervosa; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Olanzapine; Paroxetine; Psychotherapy, Brief; Serotonin Plasma Membrane Transport Proteins; Treatment Failure | 2014 |
9 other study(ies) available for homovanillic acid and paroxetine
| Article | Year |
|---|---|
Regional studies of serotonin and dopamine metabolism and quantification of serotonin uptake sites in human cerebral cortex.
Topics: Adolescent; Adult; Cerebral Cortex; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; In Vitro Techniques; Kinetics; Male; Membranes; Middle Aged; Paroxetine; Piperidines; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sex Characteristics | 1992 |
Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Atrophy; Brain; Cerebral Ventricles; Designer Drugs; Dopamine; Fenfluramine; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Organ Specificity; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism | 1992 |
The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients.
Topics: Aged; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 1994 |
Neurochemistry and paroxetine response in major depression.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paroxetine; Personality Inventory; Serotonin | 1995 |
Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Cortex; Aging; Analysis of Variance; Animals; Biogenic Monoamines; Brain; Corticosterone; Defecation; Dexamethasone; Dopamine; Female; Gestational Age; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Motor Activity; Organ Specificity; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Serotonin | 1997 |
2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Animals; Body Temperature; Brain; Carrier Proteins; Corpus Striatum; Dopamine; Drug Synergism; Frontal Lobe; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothermia; Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurotoxins; Niacinamide; Organ Specificity; Paroxetine; Rats; Rats, Wistar; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2000 |
Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cocaine; Conditioning, Psychological; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mesencephalon; Morphine; Motivation; Nucleus Accumbens; Paroxetine; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment.
Topics: Adult; Aged; Biomarkers; Cyclopropanes; Depressive Disorder; Female; Homovanillic Acid; Hospitals, University; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Milnacipran; Paroxetine; Patient Selection; Selective Serotonin Reuptake Inhibitors | 2004 |
Depressive symptoms, monoamines levels, MAO-B activity and effect of treatment in a subset of depressed individuals from government sector hospital at Karachi.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Case-Control Studies; Depression; Female; Fluoxetine; Homovanillic Acid; Hospitals, Public; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Monoamine Oxidase; Pakistan; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicidal Ideation; Treatment Outcome; Young Adult | 2017 |